Treatment of Bladder Cancer: Anti-PD-1 Drug Treatment Associated Hypothyroidism
1. Abstract Bladder cancer is a common malignant disease of the urogenital tract, and over the past few decades, immunotherapy, based on the principle of activating the patient’s immune system to root out malignant cells, has largely changed the treatment of cancer. Anti-PD-1 drugs include monoclonal antibodies against PD-1 and the PD-1 ligand (PD-L1).
Treatment of Bladder Cancer: Anti-PD-1 Drug Treatment Associated Hypothyroidism Read More »